Mainz Biomed N.V.
NASDAQ: QUCY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Guido Baechler
- Employees
- 26
- Headquarters
- Mainz, Germany
- IPO year
- 2021
- Market cap
- $19.0M
- Website
- http://mainzbiomed.com
Loading QUCY…
Loading profile data…Frequently asked questions about QUCY
What does Mainz Biomed N.V. (QUCY) do?
Mainz Biomed N.V. is a specialized enterprise in the field of molecular genetics, primarily focused on cancer diagnostics. The company's core mission involves developing and producing market-ready molecular genetic diagnostic solutions specifically engineered for life-threatening medical conditions. Beyond creation, it actively engages in the gl...
Where does QUCY trade?
Mainz Biomed N.V. (QUCY) trades on the NASDAQ Global Market.
What sector is QUCY in?
Mainz Biomed N.V. (QUCY) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Mainz Biomed N.V.?
Guido Baechler is the chief executive officer of Mainz Biomed N.V. (QUCY).
Where is Mainz Biomed N.V. headquartered?
Mainz Biomed N.V. is headquartered in Germany.
Does QUCY pay a dividend?
Mainz Biomed N.V. (QUCY) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did QUCY go public?
Mainz Biomed N.V. (QUCY) completed its initial public offering in 2021.